肠溶阿司匹林、血管紧张素转换酶抑制剂与氢氯噻嗪联用治疗高血压病及心力衰竭的疗效分析
被引量：2
摘要
自发现阿司匹林(Aspirin)具有拮抗血小板聚集的功能后，小剂量阿司匹林在心血管病治疗中得到了广泛应用，其在治疗中的积极作用也逐渐得到肯定。长效血管紧张素转换酶抑制剂(ACEI)、β受体阻滞剂在联合治疗高血压病及心力衰竭的几项大型循证医学试验中，被认为具有抑制心肌重构。
出处
《中国心血管病研究》
CAS
2004年第4期266-268,共3页
Chinese Journal of Cardiovascular Research
参考文献6
-
1[1]Hansson L. Zanchetti A. for the Hot Study Group. Effects of intensive blood pressure lowering and low close aspirin in patients with hypertension: Principal results of the hypertension optimal treatment (HOT)randomised trial[J]. Lancet, 1998,351:1755 - 1762
-
2[2]The SOLVD Investigators. Effect of enalapril in patients with reduced left ventrieular ejection fraction and congestive heart failure[J]. N Engl J Med, 1991,325: 293 - 302
-
3[3]Leor J, Reicher Reiss H, Goldbourt U, et al. Aspirin and mortality in patients treated with angiotensin- converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease[J]. J Am Coll Cardiol, 1999,33(7): 1920 - 1925
-
4[4]Peterson JG, Topol EJ, Sapp SK, et al. Evaluation of the effects of aspirin combined with angiotensin- con-verting enzyme inhibitors in patients with coronary artery disease[J]. Am J Med,2000,109(5) :371 - 377
-
5[5]The CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure: results of the cooperative North Scandinavian Enalapril Survival Study[J ]. N Engl J Med, 1987,316:1429
-
6[8]Oikawa T, Frecman M. LOW, Vaughan DE, et al.Modulation of plasminogen activator inhibitor- I in vivo: A new mechanism for the anti- fibrotic effect of renin- angiotensin inhibition [ J ]. Kidncy Int, 1997,51:164 - 172
同被引文献24
-
1杜晔,孙蔚明.血管紧张素转换酶抑制剂与利尿剂联合应用对老年人肾脏功能的影响[J].现代中西医结合杂志,2004,13(15):1998-2000. 被引量：4
-
2张言.血管紧张素转换酶抑制剂的临床应用分析[J].中西医结合心脑血管病杂志,2005,3(2):180-181. 被引量：14
-
3陈少萍,秦永文,郑兴.联合用药——高血压病人血压控制达标的基本策略[J].药学服务与研究,2006,6(6):401-405. 被引量：15
-
4Peterson J G, Topol E J, Sapp S K, et al. Evaluation of the effects of aspirin combined with angiotensin-coverting enzyme inhibitors in patients with coronary artery disease[J]. Am J Med, 2000,109(5):371-377.
-
5Leor J, Reicher-Reiss H, Goldbourt U, et al. Aspirin and mortality in patients treated with angiotensin-coverting enzyme inhibitors: a cohort study of 11 575 patients with coronary artery disease[J]. J Am Coll Cardiol, 1999,33 (7):1920- 1925.
-
6Krombach R S,Clair M J, Hendrick J W,et al. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns[J]. Cardiovasc Res, 1998,38(3) : 631-645.
-
7Swedberg K, Pfeffer M, Granger C, et al. Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators[J]. J Card Fail,1999,5(3):276-282.
-
8McKelvie R S, Yusuf S, Pericak D, et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators[J]. Circulation, 1999,100 (10) : 1056-1064.
-
9彭巍.78例老年重症心力衰竭急诊内科治疗的临床分析[J].医学信息（中旬刊）,2011,24(6):2651-2652. 被引量：56
-
10任丽萍.老年重症心力衰竭急诊内科治疗效果分析[J].中国医药导刊,2011,13(12):2143-2143. 被引量：40
引证文献2
-
1司梁宏,张梅,王达理,姚英.血管紧张素转换酶抑制剂与四类药物的联用[J].药学服务与研究,2007,7(2):103-105.
-
2胡立志,孙维兰,迮昊,顾巍峰,童武进.左西孟旦联合氢氯噻嗪治疗重症心力衰竭的临床研究[J].现代药物与临床,2024,39(1):116-120.
-
1应仲良.缬沙坦治疗轻、中度原发性高血压的疗效分析[J].浙江临床医学,2006,8(5):482-482. 被引量：1
-
2朱晓光,汪升平.225例结核菌素试验结果分析[J].安徽预防医学杂志,1997,3(2):43-44.
-
3于波,王心悦.房颤病人心脏起搏器治疗时机和类型的选择[J].中国全科医学（医生读者版）,2009(1):24-25.
-
4心血管病治疗与发生糖尿病的危险[J].高血压杂志,2005,13(2):122-122.
-
5蒋长盛.钙拮抗剂在心血管病治疗中的新认识[J].国外医学（内科学分册）,1998,25(4):150-153. 被引量：8
-
6翁晓生.略论中西药联用在心血管病治疗中的存在问题[J].浙江中医杂志,1996,31(5):229-230.
-
7重视镁在心血管病治疗中的作用[J].高血压杂志,1998,6(3):156-156.
-
8郑道声,陈大新.激光在心血管病治疗中的应用近况[J].国外医学（内科学分册）,1989,16(4):158-162.
-
9赵立坤,王朝霞,王玉霞,张宝忠.曲美他嗪治疗心肌梗死后心绞痛疗效观察[J].中国现代医药杂志,2011,13(2):88-89. 被引量：2
-
10黄敏.β受体阻滞剂在快速性心律失常中的作用[J].世界最新医学信息文摘,2015,0(52):59-59.
